Article
Association of genotype with treatment response and prognosis in dilated cardiomyopathy.
Revista espanola de cardiologia (English ed.) - 1 May 2026
Mora-Ayestarán Nerea, Ochoa Juan Pablo, Espinosa-Castro María Ángeles, Navarro-Peñalver Marina, Villacorta Eduardo, Crespo-Leiro María G, Climent-Payá Vicente, Lacuey-Lecumberri Gemma, Peña-Peña María Luisa, Bermúdez-Jiménez Francisco J, García-Pinilla José M, Mogollón-Jiménez María Victoria, Limeres-Freire Javier, García-Álvarez Ana, Bayés-Genís Antoni, Palomino-Doza Julián, Tirón Coloma, Ripoll-Vera Tomás, López Javier, Brion María, Vilches-Soria Silvia, Sabater-Molina María, García-Berrocal Belén, Larrañaga-Moreira José M, García-Álvarez María I, Basurte-Elorz María Teresa, Llamas-Gómez Helena, Méndez-Fernández Irene, Garrido-Bravo Iris Paula, González-López Esther, Gallego-Delgado María, Barriales-Villa Roberto, Lara-Pezzi Enrique, García-Pavía Pablo, Domínguez Fernando
Abstract excerpt
INTRODUCTION AND OBJECTIVES: Left ventricular reverse remodeling (LVRR) is a key therapeutic goal in dilated cardiomyopathy (DCM). However, its genetic predictors and prognostic impact remain uncertain. METHODS: We analyzed genotyped DCM patients with serial echocardiograms from the Spanish DCM study. The main objective was to assess the influence of genotype on LVRR, defined by improvement in ejection fraction...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.